Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1352415

GTEX

ce02ea36-ba30-5168-b0ee-aeb4c0c5e7fa

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.125
  • DNA_REPAIR+0.107
  • MITOTIC_SPINDLE+0.049
  • MYC_TARGETS_V2+0.048
  • SPERMATOGENESIS+0.037
  • UNFOLDED_PROTEIN_RESPONSE+0.020
  • OXIDATIVE_PHOSPHORYLATION+0.003
  • MYC_TARGETS_V1-0.017
  • PROTEIN_SECRETION-0.024
  • PI3K_AKT_MTOR_SIGNALING-0.034

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.603
  • TNFA_SIGNALING_VIA_NFKB-0.526
  • INTERFERON_GAMMA_RESPONSE-0.524
  • INFLAMMATORY_RESPONSE-0.514
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.492
  • IL6_JAK_STAT3_SIGNALING-0.472
  • ALLOGRAFT_REJECTION-0.462
  • ANGIOGENESIS-0.459
  • APOPTOSIS-0.429
  • COMPLEMENT-0.425

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1361714
brain-umap@2
GTEX0.988
2SRR1464305
brain-umap@2
GTEX0.987
3SRR1319672
brain-umap@2
GTEX0.984
4SRR1490568
brain-umap@2
GTEX0.984
5SRR1441224
brain-umap@2
GTEX0.984
6SRR1356204
brain-umap@2
GTEX0.984
7SRR1419675
brain-umap@2
GTEX0.984
8SRR807657
brain-umap@2
GTEX0.984
9SRR1456531
brain-umap@2
GTEX0.983
10SRR1499982
brain-umap@2
GTEX0.982

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 7 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.125Remibrutinib— uncovered
DNA_REPAIR0.107Idelalisib— uncovered
MITOTIC_SPINDLE0.049Inavolisib— uncovered
MYC_TARGETS_V20.048Idelalisib— uncovered
SPERMATOGENESIS0.037Inavolisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.020Idelalisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.003Remibrutinib— uncovered